These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8901827)

  • 1. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.
    Balakrishnan SM; Wang HD; Gopalakrishnan V; Wilson TW; McNeill JR
    Hypertension; 1996 Nov; 28(5):806-9. PubMed ID: 8901827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension.
    Balakrishnan SM; Gopalakrishnan V; McNeill JR
    Eur J Pharmacol; 1997 Sep; 334(1):55-60. PubMed ID: 9346328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
    Li JS; Schiffrin EL
    Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    Kost CK; Herzer WA; Li P; Jackson EK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
    Touyz RM; Fareh J; Thibault G; Schiffrin EL
    Hypertension; 1996 Nov; 28(5):797-805. PubMed ID: 8901826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1.
    Touyz RM; Tolloczko B; Schiffrin EL
    J Hypertens; 1994 Jun; 12(6):663-73. PubMed ID: 7963491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).
    Benter IF; Diz DI; Ferrario CM
    Hypertension; 1995 Dec; 26(6 Pt 2):1138-44. PubMed ID: 7498984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of cardiovascular responses to some endogenous pressor and hypotensive agents in conscious stroke-prone spontaneously hypertensive rats of different ages.
    Hara S; Matsumura M; Ueda M
    Jpn Heart J; 1993 Jul; 34(4):439-49. PubMed ID: 8246350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
    Rosen B; Barg J; Zimlichman R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade.
    Herizi A; Jover B; Bouriquet N; Mimran A
    Hypertension; 1998 Jan; 31(1):10-4. PubMed ID: 9449383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats.
    Guidi E; Hollenberg NK
    Hypertension; 1987 Jun; 9(6):591-7. PubMed ID: 3294592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ; Blaschak CM; Chinoy MR; Jackson EK
    Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ; Jackson EK
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
    Gu Y; Chen J; Yang H; Zhu W; Lin F; Zhu C; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):10-3. PubMed ID: 11953118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated pressor response to centrally administered renin in freely moving, spontaneously hypertensive rats.
    Kawasaki H; Takasaki K; Furukawa T
    Eur J Pharmacol; 1987 Jun; 138(3):351-7. PubMed ID: 3305043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.